Investigation of non-enzymatic glycosylation of human serum albumin using ion trap-time of flight mass spectrometry

Molecules

Volumn 17, Issue 8, 2012, Pages 8782-8794

  Bai, Xue ^a   Wang, Zhangjie ^a   Huang, Chengcai ^b   Wang, Zhe ^c   Chi, Lianli ^a  

^a SHANDONG UNIVERSITY   (China)

^b Life Science and Clinical Department   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Diabetes; Glycation; Human serum albumin; Incorporation ratio; Ion trap time of flight; Mass spectrometry; Peptide fingerprinting

Indexed keywords

GLYCOSYLATED SERUM ALBUMIN; PEPTIDE FRAGMENT; SERUM ALBUMIN; TRYPSIN;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ARTICLE; BLOOD; CHEMISTRY; GLYCOSYLATION; HUMAN; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METABOLISM; MOLECULAR GENETICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PEPTIDE MAPPING; PROTEIN DEGRADATION;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, AFFINITY; DIABETES MELLITUS, TYPE 2; GLYCOSYLATION; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; PROTEOLYSIS; SERUM ALBUMIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRYPSIN;

EID: 84865508878     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17088782     Document Type: Article

References (28)

1. Rondeau, P.; Bourdon, E. The glycation of albumin: Structural and functional impacts. Biochimie 2011, 93, 645-658.
2. Day, J.F.; Thorpe, S.R.; Baynes, J.W. Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum. J. Biol. Chem. 1979, 254, 595-597.
3. Sattarahmady, N.; Moosavi-Movahedi, A.A.; Ahmad, F.; Hakimelahi, G.H.; Habibi-Rezaei, M.; Saboury, A.A.; Sheibani, N. Formation of the molten globute-like state during prolonged glycation of human serum albumin. Biochim. Biophys. Acta 2007, 1770, 933-942.
4. Shaklai, N.; Garlick, R.L.; Bunn, H.F. Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J. Biol. Chem. 1984, 259, 3812-3817.
5. Takino, J.; Yamagishi, S.; Takeuchi, M. Cancer malignancy is enhanced by glyceraldehydederived advanced glycation end-products. J. Oncol. 2010, 2010, 739852.
6. Peppa, M.; Raptis, S.A. Advanced glycation end products and cardiovascular disease. Curr. Diabetes Rev. 2008, 4, 92-100.
7. Münch, G.; Deuther-Conrad, W.; Gasic-Milenkovic, J.J. Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer's disease-a target for neuroprotective treatment strategies? Neural. Transm. Suppl. 2002, 62, 303-307.
8. Roohk, H.V.; Zaidi, A.R. A review of glycated albumin as an intermediate glycation index for controlling diabetes. J. Diabetes Sci. Technol. 2008, 2, 1114-1121.
9. Takahashi, S.; Uchino, H.; Shimizu, T.; Kanazawa, A.; Tamura, Y.; Sakai, K.; Watada, H.; Hirose, T.; Kawamori, R.; Tanaka, Y. Comparison of glycated albumin (GA) and glycated hemoglobin (HbAlc) in type 2 diabetic patients: Usefulness of GA for evaluation of short term changes in glycemic control. Endocr. J. 2007, 54, 139-144.
10. Yatscoff, R.W.; Tevaarwerk, G.J.M.; MacDonald, J.C. Quantification of nonenzymically glycated albumin and total serum protein by affinity chromatography. Clin. Chem. 1984, 30, 446-449.
11. Zhang, G.; Kai, M.; Nohta, H.; Umegae, Y.; Ohkura, Y. Simultaneous determination of glycated albumin and D-Glucose in human serum by high-performance liquid chromatography with postcolumn fluorescence derivatization. Anal. Sci. 1993, 9, 9-14.
12. Lapolla, A.; Fedele, D.; Reitano, R.; Aricò, N.C.; Seraglia, R.; Traldi, P.; Marotta, E.; Tonani, R. Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides. J. Am. Soc. Mass Spectrom. 2004, 15, 496-509.
13. Mashiba, S.; Uchida, K.; Okuda, S.; Tomita, S. Measurement of glycated albumin by the nitroblue tetrazolium colorimetric method. Clin. Chim. Acta 1992, 212, 3-15.
14. Sv enfeld, A.; Pavlícv ek, Z. Nonenzymatic glycosylation of human serum albumin: Fluorescence and chemiluminescence behavior. J. Fluoresc. 1993, 3, 219-222.
15. Yasukawa, K.; Abe, F.; Shida, N.; Koizumi, Y.; Uchida, T.; Noguchi, K.; Shima, K. High-performance affinity chromatograph system for the rapid, efficient assay of glycated albumin. J. Chromatogr. 1992, 597, 271-275.
16. Iberg, N.; Flückiger, R. Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. J. Biol. Chem. 1986, 261, 13542-13545.
17. Garlick, R.L.; Mazer, J.S. The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J. Biol. Chem. 1983, 258, 6142-6146.
18. Zmatliková, Z.; Sedláková, P.; Lacinová, K.; Eckhardt, A.; Pataridis, S.; Mik sv ík, I. Non-enzymatic posttranslational modifications of bovine serum albumin by oxo-compounds investigated by high-performance liquid chromatography-mass spectrometry and capillary zone electrophoresis-mass spectrometry. J. Chromatogr. A 2010, 1217, 8009-8015.
19. Zoellner, H.; Hou, J.Y.; Hochgrebe, T.; Poljak, A.; Duncan, M.W.; Golding, J.; Henderson, T.; Lynch, G. Fluorometric and mass spectrometric analysis of nonenzymatic glycosylated albumin. Biochem. Biophys. Res. Commun. 2001, 284, 83-89.
20. Kisugi, R.; Kouzuma, T.; Yamamoto, T.; Akizuki, S.; Miyamoto, H.; Someya, Y.; Yokoyama, J.; Abe, I.; Hirai, N.; Ohnishi, A. Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin. Clin. Chim. Acta 2007, 382, 59-64.
21. Frolov, A.; Hoffmann, R. Identification and relative quantification of specific glycation sites in the human serum albumin. Anal. Bioanal. Chem. 2010, 397, 2349-2356.
22. Campbell, J.M.; Collings, B.A.; Douglas, D.J. A new linear ion trap time-of-flight system with tandem mass spectrometry capabilities. Rapid Commun. Mass Spectrom. 1998, 12, 1463-1474.
23. Collings, B.A.; Campbell, J.M.; Mao, D.; Douglas, D.J. A combined linear ion trap time-of-flight system with improved performance and MSn capabilities. Rapid Commun. Mass Spectrom. 2001, 15, 1777-1795.
24. Chen, Y.; Jin, X.; Misek, D.; Hinderer, R.; Hanash, S.M.; Lubman, D.M. Identification of proteins from two-dimensional gel electrophoresis of human erythroleukemia cells using capillary high performance liquid chromatography/electrospray-ion trap-reflection time-of-flight mass spectrometry with two-dimensional topographic map analysis of in-gel tryptic digest products. Rapid Commun. Mass Spectrom. 1999, 13, 1907-1916.
25. Huang, P.; Wall, D.B.; Parus, S.; Lubman, D.M. On-line capillary liquid chromatography tandem mass spectrometry on an Ion trap/reflection time-of-flight mass spectrometer using the sequence tag database search approach for peptide sequencing and protein identification. J. Am. Soc. Mass Spectrom. 2000, 11, 127-135.
26. Hyakkoku, K.; Hamanaka, J.; Tsuruma, K.; Shimazawa, M.; Hara, H. Proteomic approach with LCMS-IT-TOF identified an increase of Rab33B after transient focal cerebral ischemia in mice. Exp. Transl. Stroke Med. 2010, 2, 20.
27. Skinner, J.P.; Chi, L.; Ozeata, P.F.; Ramsay, C.S.; ÓHara, R.L.; Calfin, B.B.; Tetin, S.Y. Introduction of the mass spread function for characterization of protein conjugates. Anal. Chem. 2012, 84, 1172-1177.
28. Kratz, F. Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. J. Control. Release 2008, 132, 171-183.